Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

The emergence of multidrug resistance cell lines is one of the major obstacles in the success of cancer chemotherapeutic treatment. Therefore, it remains a big challenge the development of new and effective drugs to defeat cancer. The presence of nitrogen heterocycles in the architectural design of drugs has led to the discovery of new leading compounds. Herein, we report the synthesis, characterization and in vitro antiproliferative activity against six cancer cell lines of D-ribofuranoside derivatives bearing a 1,2,4-oxadiazolic ring, with the aim of developing new active compounds. Most of these derivatives exhibit significant antiproliferative activities in the micromolar range. Noteworthy, the most potent compound of the series showed better selectivity towards the more resistant colon cancer cell line WiDr. © 2017 Elsevier Ltd

Registro:

Documento: Artículo
Título:Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl D-ribofuranosides
Autor:Avanzo, R.E.; Padrón, J.M.; D'Accorso, N.B.; Fascio, M.L.
Filiación:Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Química Orgánica, Buenos Aires, Argentina
BioLab, Instituto Universitario de Bio-Orgánica “Antonio González” (IUBO-AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna, La Laguna, 38206, Spain
CONICET – Universidad de Buenos Aires, Centro de Investigaciones en Hidratos de Carbono (CIHIDECAR), Buenos Aires, Argentina
Palabras clave:1,2,4-Oxadiazole; 1,2,4-Triazole; 5-Amino-1,3,4-thiadiazole; Antiproliferative activity; D-Ribose; (5 aryl oxadiazole 3 yl) methyl dextro ribofuranoside derivative; antineoplastic agent; unclassified drug; antineoplastic agent; oxadiazole derivative; ribose; A-549 cell line; antineoplastic activity; antiproliferative activity; apoptosis; Article; cell proliferation; colon cancer cell line; controlled study; drug synthesis; G1 phase cell cycle checkpoint; HeLa cell line; human; human cell; in vitro study; lymphoma cell line; prostate cancer cell line; renal cancer cell line; structure activity relation; analogs and derivatives; chemistry; drug effects; drug screening; synthesis; tumor cell line; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Oxadiazoles; Ribose; Structure-Activity Relationship
Año:2017
Volumen:27
Número:16
Página de inicio:3674
Página de fin:3677
DOI: http://dx.doi.org/10.1016/j.bmcl.2017.07.015
Título revista:Bioorganic and Medicinal Chemistry Letters
Título revista abreviado:Bioorg. Med. Chem. Lett.
ISSN:0960894X
CODEN:BMCLE
CAS:ribose, 34466-20-1, 50-69-1, 93781-19-2; Antineoplastic Agents; Oxadiazoles; Ribose
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0960894X_v27_n16_p3674_Avanzo

Referencias:

  • Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., (2009) Science, 324, p. 1029
  • Flaveny, C.A., Griffett, K., El-Gendy, B.E.-D.M., (2015) Cancer Cell, 28, p. 1
  • Jordheim, L.P., Durantel, D., Zoulim, F., Dumontet, C., (2013) Nat Rev Drug Disc, 12, p. 447
  • Moeker, J., Mahon, B.P., Bornaghi, L.F., (2014) J Med Chem, 57, p. 8635
  • Avanzo, R.E., Anesini, C., Fascio, M.L., Errea, M.I., D'Accorso, N.B., (2012) Eur J Med Chem, 47, p. 104
  • Gueron, G., Avanzo, R.E., Schuster, F., Carabelos, M.N., Vazquez, E., Fascio, M.L., D'Accorso, N.B., (2014) Biomed Pharmacother, 68, p. 847
  • Akhtar, J., Khan, A.A., Ali, Z., Haider, R., Yar, M.S., (2017) Eur J Med Chem, 125, p. 143
  • McBriar, M.D., Clader, J.W., Chu, I., (2008) Bioorg Med Chem Lett, 18, p. 215
  • Gilmore, J.L., Sheppeck, J.E., Watterson, S.H., (2016) J Med Chem, 59, p. 6248
  • Rosenberg, A.J., Liu, H., Jin, H., Yue, X., Riley, S., Brown, S.J., Tu, Z., (2016) J Med Chem, 59, p. 6201
  • Maftei, C.V., Fodor, E., Jones, P.G., (2016) Tetrahedron, 72, p. 1185
  • Han, M., Li, S., Ai, J., (2016) Bioorg Med Chem Lett, 26, p. 5679
  • Jain, A.K., Sharma, S., Vaidya, A., Ravichandran, V., Agrawal, R.K., (2013) Chem Biol Drug Des, 81, p. 557
  • Shi, W., Hu, J., Bao, N., Li, D., Chen, L., Sun, J., (2017) Bioorg Med Chem Lett, 27, p. 147
  • Nieto, D., Bruña, S., González-Vadillo, A.M., (2015) Organometallics, 34, p. 5407

Citas:

---------- APA ----------
Avanzo, R.E., Padrón, J.M., D'Accorso, N.B. & Fascio, M.L. (2017) . Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl D-ribofuranosides. Bioorganic and Medicinal Chemistry Letters, 27(16), 3674-3677.
http://dx.doi.org/10.1016/j.bmcl.2017.07.015
---------- CHICAGO ----------
Avanzo, R.E., Padrón, J.M., D'Accorso, N.B., Fascio, M.L. "Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl D-ribofuranosides" . Bioorganic and Medicinal Chemistry Letters 27, no. 16 (2017) : 3674-3677.
http://dx.doi.org/10.1016/j.bmcl.2017.07.015
---------- MLA ----------
Avanzo, R.E., Padrón, J.M., D'Accorso, N.B., Fascio, M.L. "Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl D-ribofuranosides" . Bioorganic and Medicinal Chemistry Letters, vol. 27, no. 16, 2017, pp. 3674-3677.
http://dx.doi.org/10.1016/j.bmcl.2017.07.015
---------- VANCOUVER ----------
Avanzo, R.E., Padrón, J.M., D'Accorso, N.B., Fascio, M.L. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl D-ribofuranosides. Bioorg. Med. Chem. Lett. 2017;27(16):3674-3677.
http://dx.doi.org/10.1016/j.bmcl.2017.07.015